| scholarly article | Q13442814 |
| P50 | author | Ab Osterhaus | Q354237 |
| P2093 | author name string | D J Smith | |
| R A M Fouchier | |||
| A R Fooks | |||
| J L N Wood | |||
| L M McElhinney | |||
| C A Russell | |||
| N Lewis | |||
| I V Kuzmin | |||
| D L Horton | |||
| D A Marston | |||
| P2860 | cites work | Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody | Q45754757 |
| Avirulent mutants of rabies virus and their use as live vaccine | Q45778815 | ||
| Cross protection of mice against different rabies virus isolates. | Q45848680 | ||
| DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses | Q48026662 | ||
| Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis | Q48218249 | ||
| Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2. | Q50726409 | ||
| Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies | Q67994472 | ||
| Antigenic variants of rabies virus | Q72678355 | ||
| Fatal human infection with rabies-related Duvenhage virus, South Africa | Q24628684 | ||
| Antigenicity of rabies virus glycoprotein | Q24653467 | ||
| Bats: important reservoir hosts of emerging viruses | Q27473464 | ||
| Mapping the antigenic and genetic evolution of influenza virus | Q29617255 | ||
| Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans | Q29619059 | ||
| Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans | Q33514828 | ||
| Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity | Q33838289 | ||
| New lyssavirus genotype from the Lesser Mouse-eared Bat (Myotis blythi), Kyrghyzstan | Q33965023 | ||
| Ecology of rabies virus exposure in colonies of Brazilian free-tailed bats (Tadarida brasiliensis) at natural and man-made roosts in Texas | Q34152250 | ||
| Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition | Q34419169 | ||
| The global circulation of seasonal influenza A (H3N2) viruses | Q34771174 | ||
| Quantifying the impact of immune escape on transmission dynamics of influenza | Q35012029 | ||
| Practical significance of rabies antibodies in cats and dogs | Q35630873 | ||
| Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe | Q35785334 | ||
| Bat-associated rabies virus in Skunks | Q35793188 | ||
| Cross-protection of mice against a global spectrum of rabies virus variants | Q35845061 | ||
| Re-evaluating the burden of rabies in Africa and Asia. | Q36174024 | ||
| Vaccines for lyssaviruses other than rabies | Q36238718 | ||
| Lagos bat virus in Kenya | Q36539910 | ||
| Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence | Q36825571 | ||
| Vaccines and viral antigenic diversity. | Q36882907 | ||
| Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein | Q36899577 | ||
| Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. | Q37410530 | ||
| Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders | Q39606804 | ||
| Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin | Q40316237 | ||
| Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses | Q40505899 | ||
| Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies | Q40579109 | ||
| Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR. | Q40767596 | ||
| Dynamics of rabies virus quasispecies during serial passages in heterologous hosts | Q40932481 | ||
| Antibodies against Lagos bat virus in megachiroptera from West Africa | Q42119773 | ||
| Phylogeography, population dynamics, and molecular evolution of European bat lyssaviruses | Q42265099 | ||
| Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region | Q42615215 | ||
| Efficacy of rabies biologics against new lyssaviruses from Eurasia | Q43218841 | ||
| Ability of rabies vaccine strains to elicit cross-neutralising antibodies | Q43221054 | ||
| Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. | Q43560703 | ||
| Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences | Q44034725 | ||
| Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses | Q44460690 | ||
| Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor | Q45270047 | ||
| Phylogeny of Lagos bat virus: challenges for lyssavirus taxonomy | Q45396324 | ||
| Genetic constraints and the adaptive evolution of rabies virus in nature | Q45733471 | ||
| Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures | Q45742665 | ||
| Ecology and evolution of rabies virus in Europe | Q45746135 | ||
| Immunization of dogs with a DNA vaccine induces protection against rabies virus | Q45746793 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 11841-11848 | |
| P577 | publication date | 2010-09-08 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Quantifying antigenic relationships among the lyssaviruses | |
| P478 | volume | 84 |
| Q34505462 | Achieving population-level immunity to rabies in free-roaming dogs in Africa and Asia |
| Q36057713 | An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines |
| Q89629008 | An inter-laboratory trial as a tool to increase rabies diagnostic capabilities of Sub-Saharan African Veterinary laboratories |
| Q36036198 | Antigenic Relationships among Human Pathogenic Orientia tsutsugamushi Isolates from Thailand |
| Q37698084 | Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus |
| Q49436056 | Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation |
| Q39067435 | Antigenic variation of foot-and-mouth disease virus serotype A. |
| Q34298720 | Bat rabies surveillance in Europe |
| Q64231999 | Bats and Viruses: Emergence of Novel Lyssaviruses and Association of Bats with Viral Zoonoses in the EU |
| Q33918621 | Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus |
| Q30875451 | Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species |
| Q38211810 | Current status of rabies and prospects for elimination |
| Q38126825 | Deciphering serology to understand the ecology of infectious diseases in wildlife. |
| Q28601417 | Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis |
| Q41926166 | Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2. |
| Q33816066 | Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody. |
| Q37470270 | Evaluation of rabies biologics against Irkut virus isolated in China |
| Q35961340 | Flavivirus-induced antibody cross-reactivity |
| Q35844668 | Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet |
| Q31154831 | Inferring infection hazard in wildlife populations by linking data across individual and population scales |
| Q37006752 | Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein. |
| Q56766468 | Jet set pets: examining the zoonosis risk in animal import and travel across the European Union |
| Q98735785 | Leveraging a Validated in silico Approach to Elucidate Genotype-Specific VP7 Epitopes and Antigenic Relationships of Porcine Rotavirus A |
| Q55404565 | Maternal antibody and the maintenance of a lyssavirus in populations of seasonally breeding African bats. |
| Q44538847 | Molecular characterization of China human rabies vaccine strains |
| Q38039471 | Molecular epidemiology of bat lyssaviruses in Europe. |
| Q34791437 | Next generation sequencing of viral RNA genomes |
| Q41993857 | Novel lyssavirus in Natterer's bat, Germany |
| Q38006132 | Passive immunity in the prevention of rabies. |
| Q36788708 | Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans. |
| Q41924718 | Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine |
| Q39084014 | Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans |
| Q38053739 | Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine? |
| Q89695673 | Rabies virus-neutralising antibodies in healthy, unvaccinated individuals: What do they mean for rabies epidemiology? |
| Q34334103 | Sequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells |
| Q89976806 | Serological Survey of Lyssaviruses in Polish Bats in the Frame of Passive Rabies Surveillance Using an Enzyme-Linked Immunosorbent Assay |
| Q28564049 | The Global Phylogeography of Lyssaviruses - Challenging the 'Out of Africa' Hypothesis |
| Q39355076 | Twenty years of active bat rabies surveillance in Germany: a detailed analysis and future perspectives. |
| Q54255407 | Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses. |
Search more.